Advertising Disclosure Email Disclosure

Matthew P. Keris Appointed State Representative to the DRI by the Pennsylvania Defense Institute

April 19, 2017

Matthew P. Keris, shareholder in the Scranton office of Marshall Dennehey Warner Coleman & Goggin, has been appointed state representative to the Defense Research Institute (DRI) by the Pennsylvania Defense Institute (PDI). In this capacity, he will act as the official liaison between the two defense litigation organizations. Mr. Keris joined the PDI in 2007 and is a former president of the organization.

He is a member of the Health Care Department at Marshall Dennehey, where he represents physicians, medical groups and health care institutions in a variety of health care liability matters. In addition to his defense practice, he lectures nationally on litigation issues pertaining to the use of electronic medical records and is the author of the book, Electronic Medical Records and Litigation, published by Thomson Reuters.

Mr. Keris is a past president of the Pennsylvania Association of Health Care Risk Management and a member of the Claims & Litigation Management Alliance (CLM) and the Pennsylvania Bar Association. A graduate of Shippensburg University and Roger Williams University School of Law, he is admitted to practice in Pennsylvania and New York.

Affiliated Attorneys

Matthew P. Keris
Shareholder
(570) 496-4602
mpkeris@mdwcg.com

Offices

Related Practice Areas

Before you send this email please note:

You are attempting to send email, through a link on our website, to an attorney of Marshall Dennehey Warner Coleman & Goggin or an employee in our firm. Please note that your email may not be treated as confidential and does not create an attorney-client relationship. You should not rely upon the transmission of an email through this website if you are seeking to enter into such a relationship. Until such time as we have agreed to represent you, no information in your email will be treated as confidential. Please contact us directly by telephone at 1.800.220.3308 if it is your intent to seek legal counsel with our firm or convey confidential information.

If it is still your intent to send this email, knowing that it may not be treated as confidential, you may accept our terms of agreement by pressing "OK". If you choose not to accept these terms of agreement you may navigate away from this page by pressing "Cancel."